12-lipoxygenase
Selected indexed studies
- Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. (Prog Lipid Res, 2019) [PMID:30472260]
- Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species. (Cell Metab, 2021) [PMID:34536344]
- Arachidonate 12-lipoxygenase. (J Lipid Mediat Cell Signal, 1995) [PMID:8777566]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Key Role of 12-Lipoxygenase and Its Metabolite 12-Hydroxyeicosatetraenoic Acid (12-HETE) in Diabetic Retinopathy. (2022) pubmed
- Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. (2019) pubmed
- Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species. (2021) pubmed
- Arachidonate 12-lipoxygenase. (1995) pubmed
- 12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice. (2024) pubmed
- Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy. (2017) pubmed
- 12-lipoxygenase: a potential target for novel anti-platelet therapeutics. (2011) pubmed
- The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease. (2015) pubmed
- 12/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance. (2012) pubmed
- 12-Lipoxygenase, 12(S)-HETE, and cancer metastasis. (1994) pubmed